Literature DB >> 6510946

Stimulatory effect of Propionibacterium granulosum KP-45, glucan and pyran copolymer on the activity of natural killer (NK) cells in murine lungs.

M Janiak, W Budzynski, B Gnatowski, C Radzikowski, S Szmigielski, J Jeljaszewicz, G Pulverer.   

Abstract

Propionibacterium granulosum KP-45, glucan and pyran copolymer stimulated the elimination of 75Selenomethionine-labelled 3LL tumor cells from murine lungs, as measured 4 hr after intravenous injection of these cells into 16- to 25-week-old B6DF1 mice. This effect was most pronounced 4 to 6 days following intravenous administration of the above biological response modifiers and disappeared 6 to 8 days later. Intraperitoneal injection of all three agents produced only insignificant stimulation results. Spontaneous clearance of 3LL cells from lungs of 8-week-old B6DF1 mice was significantly more effective than in animals over 16 weeks old. Cyclophosphamide suppressed the elimination of tumor cells from lungs in both young and older mice and neutralized the stimulatory effect of P. granulosum KP-45 and glucan. The results suggest that the effector cells responsible for the clearance of radiolabelled 3LL cells from lungs of B6DF1 mice are at least similar to natural killer (NK) lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6510946     DOI: 10.1016/S0171-2985(84)80004-2

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  3 in total

1.  Combined immunostimulation (Propionibacterium avidum KP 40) and anticoagulation (heparin) prevents metastatic lung and liver colonization in mice.

Authors:  J Beuth; H L Ko; G Uhlenbruck; G Pulverer
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

2.  Update on the immunomodulating activities of glucans.

Authors:  N R Di Luzio
Journal:  Springer Semin Immunopathol       Date:  1985

3.  Augmentation of natural cell activity in tumor-bearing and normal mice by MVE-2.

Authors:  W Budzynski; M Chirigos; E Gruys
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.